Target organ involvement in hypertension: a realistic promise of prevention and reversal

Area of Science:

• Cardiology
• Nephrology
• Hypertension Research

Background:

• Hypertensive disease leads to severe complications including stroke, coronary heart disease (CHD), and hypertensive emergencies, which are largely preventable.
• Cardiac failure and end-stage renal disease (ESRD) remain common, disabling, and fatal outcomes of long-standing hypertension.
• Hypertension and diabetes mellitus are primary drivers of cardiac failure and ESRD, respectively.

Purpose of the Study:

• To discuss the preventable and non-preventable end points of hypertensive disease.
• To elucidate the underlying mechanisms of target organ damage in hypertension.
• To highlight the impact of modern therapy on hypertension-related complications.

Main Methods:

• Review of current understanding of hypertensive disease end points.
• Analysis of mechanisms contributing to target organ damage (ischemia, fibrosis, apoptosis).
• Evaluation of the efficacy of contemporary therapeutic strategies.

Main Results:

• Stroke, CHD, and hypertensive emergencies are preventable end points of hypertension.
• Cardiac failure and ESRD remain significant causes of morbidity and mortality.
• Current therapies can reverse complications, and early intervention may prevent them.

Conclusions:

• Early detection and treatment of hypertension are crucial for preventing cardiac and renal failure.
• Effective arterial pressure control and addressing underlying disease mechanisms reduce the prevalence of these failures.
• Modern pharmacologic agents show promise in preventing the occurrence and consequences of hypertension-related organ damage.